Notably, INSM1 has been demonstrated to be highly expressed in SCLC, carcinoid tumors, and in the SCLC-like molecular subtype of LCNEC, while generally absent in non-neuroendocrine NSCLCs [19,24]. Here, INSM1 is linked to large cell neuroendocrine carcinoma.